Services

Four services for the decisions sponsors actually face.

Use the Snapshot before the U.S. path is set. Use FIH Scout Plus when the synopsis and CRO conversations are forming. Use CRO Acceleration when a CRO is already engaged but site and patient assumptions need sharper review. Use the RWD-enabled package only when cohort or site feasibility needs deeper support.

Strategy team reviewing oncology FIH readiness signals on a conference screen.

01Price: $10,000-$15,000Timeline: 7-10 business days

FIH Readiness Snapshot

A focused readiness assessment for sponsors considering U.S. pre-IND, FIH, or Phase 1 planning but not yet sure whether the asset is ready for serious CRO execution.

Best fitDefined oncology asset, target, mechanism, modality, and preliminary indication.Deliverable15-25 page diagnostic memo, readiness conclusion, risk flags, and one readout call.View FIH Readiness Snapshot

Clinical development team studying trial landscape and site strategy dashboards.

02Price: $45,000-$72,000Timeline: 3-4 weeks

FIH Scout Plus

The core OncoLattice strategy package for sponsors preparing U.S. pre-IND, FIH, or Phase 1 development before major execution budgets are committed.

Best fitDraft protocol synopsis or early development plan with uncertainty around U.S. execution assumptions.Deliverable50-80 page strategy report, 10-page executive deck, CRO briefing questions, and sponsor decision memo.View FIH Scout Plus

Sponsor team reviewing CRO workflow, site prioritization, and patient distribution dashboards.

03Price: $35,000-$85,000 + data cost if usedTimeline: 2-4 weeks

CRO Acceleration Intelligence

For sponsors that already selected a CRO or are moving through CRO startup, this package uses FIH Scout and compliance-aware RWD feasibility logic to accelerate site prioritization, patient distribution review, and CRO assumption testing.

Best fitCRO already engaged, first-wave site list or startup plan available, and sponsor needs sharper prioritization before execution drifts.DeliverableCRO acceleration memo, site priority challenge list, patient distribution review, CRO meeting questions, and next-action tracker.View CRO Acceleration

Analysts reviewing cohort feasibility, protocol risk, and site strategy charts.

04Price: $115,000-$190,000 + data costTimeline: 6-8 weeks

RWD-Enabled Cohort & Site Strategy

An advanced, compliance-aware strategy package for sponsors that need to evaluate whether the proposed U.S. target cohort is realistically available and whether the site strategy is supported by real-world feasibility logic.

Best fitDefined U.S. FIH or Phase 1 plan with biomarker, line-of-therapy, or cohort availability uncertainty.Deliverable80-120 page strategy report, RWD feasibility framework, protocol risk redline, site archetype strategy, and sponsor readout.View RWD-Enabled Strategy